Novo Nordisk’s weight loss injection semaglutide — the ingredient inside its wildly popular drugs Ozempic and Wegovy — could ...
Weight loss jabs like Ozempic cuts risk of heart attack and stroke, study claims - Risk of serious conditions reduced ...
Those taking the drugs for at least three years cut their risk of heart attack, stroke or cardiac death by 20 per cent ...
Find your bookmarks in your Independent Premium section, under my profile Weight loss jabs like Ozempic can cut the risk of heart attacks or strokes by a fifth, a “game-changing” new study has ...
Weight loss injections like Ozempic might be a game-changer for heart health. A new study suggests these drugs can significantly reduce the risk of heart attacks and strokes in obese patients ...
The weight loss jab has become a blockbuster pharmaceutical hit, with people, including the diabetics it was originally ...
A study has found the anti-obesity drug sold under brand names Wegovy, Ozempic and Rybelsus could reduce the risk of heart attacks, strokes ...
New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular ...
A weight loss injection could reduce the risk of heart attacks and benefit the cardiovascular health of adults, according to a study on what could be the largest medical breakthrough since statins.
As a major study shows it cuts heart attack risks experts say semaglutide could 'transform many chronic diseases of ageing' ...